Phospholipase A2 inhibitory activity in lung cancer cell lines.
Abe
M
M
Department of Pharmacology, Fukuoka University School of Medicine, Japan.
Sakurada
T
T
Kuwata
H
H
Nakatani
Y
Y
Kudo
I
I
Furukawa
T
T
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000096:biosynthesis; D000230:Adenocarcinoma / Q000503:physiopathology; D000001:Calcimycin / Q000494:pharmacology*; D018288:Carcinoma, Small Cell / Q000503:physiopathology; D002294:Carcinoma, Squamous Cell / Q000503:physiopathology; D002450:Cell Communication; D002460:Cell Line; D018920:Coculture Techniques; D004912:Erythrocytes / Q000502:physiology*; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000096:biosynthesis; D007975:Leukotriene B4 / Q000096:biosynthesis*; D008175:Lung Neoplasms / Q000503:physiopathology*; D008954:Models, Biological; D009504:Neutrophils / Q000201:enzymology / Q000502:physiology*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D014407:Tumor Cells, Cultured
D006893:Hydroxyeicosatetraenoic Acids; D007975:Leukotriene B4; D000001:Calcimycin; C022022:5-hydroxy-6,8,11,14-eicosatetraenoic acid; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D010741:Phospholipases A; D054467:Phospholipases A2